Brea, California, June 15, 2015 – PharMedQuest, provider of ARC™, announces today the appointment of Kirby Eng, R.Ph. to the position of Executive Director of Business Development for ARC™. In this role, Mr. Eng will be part of the NS and Associates, LLC and ARC™ management team and will lead their payer strategies and engagements.
Known for the depth and breadth of his business and clinical successes throughout his career, Mr. Eng brings to ARC™ over 16 years of Specialty Medications and Oncology experience, thought leadership, and a strong track record of delivering results. Now armed with ARC™, a proven end-to-end medical specialty drug solution for payers, Kirby can provide real-time intelligence and discuss actionable solutions to address challenges with national and regional clients.
Mr. Eng’s past experiences include CuraScript, U.S. Oncology, Oncology Therapeutics Network, Onco360, Sicor Pharmaceuticals and Eli Lilly, and Co. Most recently, Mr. Eng worked for CVS Caremark Specialty where he led and supported oncology drug management initiatives for payer clients.
PharMedQuest is a national leader in providing proven cost-effective solutions to some of the most challenging issues in healthcare. We are dedicated to providing transparent and innovative drug management solutions that optimize the clinical, operational and financial complexities of medical specialty drug management for cancer and other complex and rare diseases.
With over 20 years of Experience, PharMedQuest delivers Insight and Value to its Clients through its services, which include holistic Medical Benefit drug management, real-time access to integrated drug utilization and financial metrics and intelligence, comprehensive 340B management, and many other integrated Pharmacy and Medical solutions that go beyond traditional PBM, Specialty Pharmacy, or Utilization Management tools. For more information about PharMedQuest services, call (714) 364-4008 or visit www.PharMedQuest.com.